Market Tracker

09/02 6:05pm ET

SPDR S&P Biotech ETF (XBI)

Data as of Sep 02
 -1.35 / -0.83%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.


1 month+8.97% 3 years+37.86%
3 months+21.76% 5 years+24.67%
1 year+35.24% Since inception+15.16%
Data through 08/30/2014

Quote Details

Previous close$161.95
Open day’s range159.86 – 163.01
Net asset value (NAV)162.07 (08/29/2014)
Daily volume276,837
Average volume (3 months)437,403
Data as of 8:00pm ET, 09/02/2014

Peer Comparisonvs. Health ETFs

Performance 5-yr return+24.67%+24.14%
Expense Gross exp ratio0.35%0.43%
Risk 5 year sharpe ratio0.901.41
Net assets$1.1B$1.3B
Average market cap$2.0B$28.6B
Average P/E--25.7
Dividend / Share--0.21%


VHT Vanguard Health Care Index Fund ETF Shar...
XLV Health Care Select Sector SPDR Fund
RYH Guggenheim S&P 500® Equal Weight Health...


Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
PBYI Puma Biotechnology Inc4.94%
INSM Insmed Inc1.82%
PCYC Pharmacyclics Inc1.68%
VRTX Vertex Pharmaceuticals Inc1.61%
EXEL Exelixis Inc1.53%
INO Inovio Pharmaceuticals Inc1.53%
GILD Gilead Sciences Inc1.50%
DYAX Dyax Corp1.48%
BCRX Biocryst Pharmaceuticals Inc1.46%
ONVO Organovo Holdings Inc1.46%